영문으로 운영되고 있는 삼성바이오에피스 SNS에 포스팅된 글입니다.
[Re:Access] Biosimilar Regulation is Improving, But Still Needs Work
2025/11/03
Samsung Bioepis Welcomes FDA's Move to Accelerate Biosimilar Development
2025/10/31
Samsung Bioepis Wins ‘Biosimilar Initiative of the Year’ at the Global Gene...
2025/10/31
[Re:Access] Why Biosimilars are Vital to Sustaining Healthcare Systems
2025/10/02
[Re:Access] The Future of Healthcare Needs Biosimilars
2025/09/19
Samsung Bioepis Sustainability Report 2025: Advancing Passion for Health th...
2025/07/08